Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Showing 1–5 of 10 stories
Latest story
Bristol Myers Squibb (BMS) announced positive topline results from the Phase 3 ALOFT-IPF trial evalu...
Read story
Nuravax, Inc. and the Institute for Molecular Medicine (IMM) have announced the publication of Phase...
Read story
Exploratory EPICS-III Trial Analysis Shows Biochemical Responses in U.S. and Non-U.S. Patients With...
Read story
The investigational long-acting antiviral drug-Fc conjugate will be evaluated in a U.S. Phase II tri...
Read story
Interim Follow-Up Data Show Durable Reductions in Urinary Leakage and Incontinence Episodes, With a...
Read storyPage 1 of 2